Gene · 1301
Papers2,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blood-based DNA methylation in advanced Nasopharyngeal Carcinoma exhibited distinct CpG methylation signature. | Sci Rep | 2023 | 38086861 | PubTator, text mining | PubMed |
| Molecular mechanisms of pruritus in prurigo nodularis. | Front Immunol | 2023 | 38077377 | PubTator, text mining | PubMed |
| CTSK and PLAU as Prognostic Biomarker and Related to Immune Infiltration in Pancreatic Cancer: Evidence from Bioinformatics Analysis and qPCR. | Int J Genomics | 2023 | 38077303 | PubTator, text mining | PubMed |
| Differential molecular profiles and associated functionalities characterize connective tissue grafts obtained at different locations and depths in the human palate. | Int J Oral Sci | 2023 | 38072943 | PubTator, text mining | PubMed |
| Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis. | Int J Mol Sci | 2023 | 38068961 | PubTator, text mining | PubMed |
| CAR NK Cell Therapy for the Treatment of Metastatic Melanoma: Potential & Prospects. | Cells | 2023 | 38067178 | PubTator, text mining | PubMed |
| Multidimensional analysis to elucidate the possible mechanism of bone metastasis in breast cancer. | BMC Cancer | 2023 | 38066539 | PubTator, text mining | PubMed |
| An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma. | Heliyon | 2023 | 38053861 | PubTator, text mining | PubMed |
| Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness. | Sci Rep | 2023 | 38049490 | PubTator, text mining | PubMed |
| Identification of differentially expressed genes associated with the pathogenesis of gastric cancer by bioinformatics analysis. | BMC Med Genomics | 2023 | 38041130 | PubTator, text mining | PubMed |
| MiR-1246b, a novel miRNA molecule of extracellular vesicles in bronchoalveolar lavage fluid, promotes nodule growth through FGF14 in patients with lung cancer. | Cell Death Dis | 2023 | 38040694 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Among School-Aged Children With High Myopia. | JAMA Netw Open | 2023 | 38039006 | PubTator, text mining | PubMed |
| Association of body mass index and PXDNL gene variants with acute primary angle closure in southern Chinese population. | Heliyon | 2023 | 38034647 | PubTator, text mining | PubMed |
| Comprehensive Transcriptomic Investigation of Rett Syndrome Reveals Increasing Complexity Trends from Induced Pluripotent Stem Cells to Neurons with Implications for Enriched Pathways. | ACS Omega | 2023 | 38027357 | PubTator, text mining | PubMed |
| Genomic profiling and immune landscape of olfactory neuroblastoma in China. | Front Oncol | 2023 | 38023213 | PubTator, text mining | PubMed |
| Revealing the impact of TOX3 on osteoarthritis: insights from bioinformatics. | Front Med (Lausanne) | 2023 | 38020130 | PubTator, text mining | PubMed |
| Papain-Based Solubilization of Decellularized Extracellular Matrix for the Preparation of Bioactive, Thermosensitive Pregels. | Biomacromolecules | 2023 | 38009757 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment. | Int J Mol Sci | 2023 | 38003695 | PubTator, text mining | PubMed |
| Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN. | Int J Mol Sci | 2023 | 38003694 | PubTator, text mining | PubMed |
| Unraveling Connective Tissue Growth Factor as a Therapeutic Target and Assessing Kahweol as a Potential Drug Candidate in Triple-Negative Breast Cancer Treatment. | Int J Mol Sci | 2023 | 38003505 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1301/papers?page=13